Bottom line
HLHIX vs FHLC: the short answer
HLHIX (Virtus KAR Health Sciences Fund) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 24 for HLHIX, so beyond the top names it adds exposure HLHIX doesn't have.
FHLC is cheaper at 0.084% vs 1.05% — a difference of $97 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +3.8% for HLHIX (reporting dates differ).
Updated Nov 19, 2026
HLHIX vs FHLC side by side
| HLHIX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Virtus | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.05% | 0.084% |
| Annual cost per $10k | $105 | $8.4 |
| 10-yr cost on $10k (prospectus) | $1,367 | $108 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +7.6% | +2.6% |
| 5-yr return (annualized) | +3.8% | +7.2% |
| 10-yr return (annualized) | +7.1% | +8.8% |
| Best quarter | +16.5% | +16.4% |
| Worst quarter | −11.8% | −13.1% |
| Net assets (fund) | $91.7M | $3.3B |
| Number of holdings | 24 | 337 |
| Portfolio turnover | 13% | 3% |
| Returns as of | Dec 31, 2025 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HLHIX | FHLC | Difference |
|---|---|---|---|
| 2024 | −2.0% | +2.6% | −4.6% |
| 2023 | +2.8% | +2.5% | +0.4% |
| 2022 | −11.6% | −5.5% | −6.1% |
| 2021 | +25.7% | +20.4% | +5.4% |
| 2020 | +14.1% | +18.1% | −4.1% |
Source: Fund prospectus bar charts
Holdings overlap
11 of HLHIX's top 24 holdings also appear in FHLC's top 25.
| Holding | HLHIX | FHLC |
|---|---|---|
| Eli Lilly & Company | 14.84% | 13.35% |
| Abbvie Inc | 5.52% | 6.42% |
| Vertex Pharmaceuticals Inc | 5.32% | 1.76% |
| Merck & Company Inc | 5.06% | 4.66% |
| Unitedhealth Group Inc | 4.65% | 5.44% |
| Mckesson Corp | 4.57% | 1.52% |
| Intuitive Surgical Inc | 3.89% | 1.82% |
| Amgen Inc | 3.85% | 3.00% |
| Thermo Fisher Scientific Inc | 3.65% | 3.09% |
| Danaher Corp | 3.37% | 1.80% |
| Regeneron Pharmaceuticals Inc | 2.90% | 1.15% |
Source: SEC Form N-PORT
HLHIX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between HLHIX and FHLC?
Which is cheaper, HLHIX or FHLC?
Should I own both HLHIX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.